Clinical Trial Update: Avacopan Added to Standard-of-care Therapy in ANCA-associated Vasculitis With Severe Kidney Involvement [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating adding avacopan to standard-of-care therapy for ANCA-associated vasculitis with severe kidney involvement.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis

Drugs mentioned

• Avacopan (avacopan)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: ANCA-Associated Vasculitis (AAV) | Phase 3 | Status: NOT_YET_RECRUITING